Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104919) titled 'A clinical study in healthy volunteers to compare the safety of VRP-034 with an existing polymyxin B medicine, including how the drug moves through the body and its effects on kidney function' on Feb. 26.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Investigator Blinded

Primary Sponsor: Venus Remedies Limited

Intervention: Intervention1: VRP-034: Novel formulati...